tiprankstipranks
Fate Therapeutics (FATE)
NASDAQ:FATE

Fate Therapeutics (FATE) Technical Analysis

1,112 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Fate Therapeutics’s (FATE) Moving Averages Convergence Divergence (MACD) indicator is 0.15, suggesting Fate Therapeutics is a Sell.
Fate Therapeutics’s (FATE) 20-Day exponential moving average is 3.76, while Fate Therapeutics’s (FATE) share price is $4.27, making it a Buy.
Fate Therapeutics’s (FATE) 50-Day exponential moving average is 3.92, while Fate Therapeutics’s (FATE) share price is $4.27, making it a Buy.

Fate Therapeutics (FATE) Pivot Points

Jul 22, 2024, 08:16 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.80
4.01
4.16
4.37
4.52
4.73
4.88
Fibonacci
4.01
4.15
4.23
4.37
4.51
4.59
4.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Fate Therapeutics (FATE) Moving Averages

Jul 22, 2024, 08:16 AM
Period
Simple
Exponential
MA5
4.30Sell
4.19Buy
MA10
3.79Buy
3.95Buy
MA20
3.59Buy
3.76Buy
MA50
3.69Buy
3.92Buy
MA100
4.96Sell
4.27Buy
MA200
4.25Buy
3.91Buy
Fate Therapeutics’s (FATE) 10-Day exponential moving average is 3.95, while Fate Therapeutics’s (FATE) share price is $4.27, making it a Buy.
Fate Therapeutics’s (FATE) 100-Day exponential moving average is 4.27, while Fate Therapeutics’s (FATE) share price is $4.27, making it a Buy.
Fate Therapeutics’s (FATE) stock price is $4.27 and Fate Therapeutics’s (FATE) 50-day simple moving average is 3.69, creating a Buy signal.
Fate Therapeutics’s (FATE) stock price is $4.27 and Fate Therapeutics’s (FATE) 100-day simple moving average is 4.96, creating a Sell signal.
Fate Therapeutics’s (FATE) stock price is $4.27 and Fate Therapeutics’s (FATE) 200-day simple moving average is 4.25, creating a Buy signal.

Fate Therapeutics (FATE) Technical Indicators

Jul 22, 2024, 08:16 AM
Name
Value
Implied Action
RSI (14)
64.10
Neutral
STOCH (9,6)
66.92
Neutral
STOCHRSI (14)
66.92
Neutral
MACD (12,26)
0.15
Sell
ADX (14)
23.60
Neutral
Williams %R
-36.96
Buy
CCI (14)
112.57
Sell
ATR (14)
0.32
-
Ultimate Oscillator
55.83
Neutral
ROC
30.18
Buy
Fate Therapeutics’s (FATE) Relative Strength Index (RSI) is 64.10, creating a Neutral signal.
Fate Therapeutics’s (FATE) Trend Strength Indicator (ADX) is 23.60, creating a Neutral signal.
Fate Therapeutics’s (FATE) Commodity Channel Index (CCI) is 112.57, creating a Sell signal.
Fate Therapeutics’s (FATE) Price Rate of Change (ROC) is 30.18, creating a Buy signal.

FAQ

Is FATE a Buy, Hold, or Sell?
Based on FATE’s technical indicators, FATE is a Buy.
    What is FATE’s RSI (14)?
    FATE’s RSI (14) is 64.10, which suggests FATE is a Neutral.
      What is FATE’s MACD?
      FATE’s MACD is 0.15, which suggests FATE is a Sell.
        What is FATE’s 5-day moving average?
        FATE’s 5-day moving average is 4.30, which suggests FATE is a Sell.
          What is FATE’s 20-day moving average?
          FATE 20-day moving average is 3.59, which suggests FATE is a Buy.
            What is FATE’s 50-day moving average?
            FATE’s 50-day moving average is 3.69, which suggests FATE is a Buy.
              What is FATE’s 200-day moving average?
              FATE’s 200-day moving average is 4.25, which suggests FATE is a Buy.
                What is FATE’s Williams % R (14)?
                FATE’s Williams % R (14) is -36.96, which suggests FATE is a Buy.
                  What is FATE’s CCI (14)?
                  FATE’s CCI (14) is 112.57, which suggests FATE is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis